Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a huma...
Q2 2025
Jun 29, 2025
FY 2023
May 10, 2024
Q2 2023
Jun 30, 2023
FY 2022
Apr 26, 2023
Q4 2022
Dec 31, 2022
